Open Access

An overview of seventy years of research (1944 – 2014) on toxoplasmosis in Colombia, South America

  • William Alberto Cañón-Franco1, 2Email author,
  • Natalia López-Orozco1,
  • Jorge Enrique Gómez-Marín3 and
  • Jitender P Dubey4
Parasites & Vectors20147:427

https://doi.org/10.1186/1756-3305-7-427

Received: 12 June 2014

Accepted: 22 August 2014

Published: 4 September 2014

Abstract

This paper summarizes prevalence of Toxoplasma gondii in humans and animals and associated correlates of infection, clinical spectrum of disease in humans, and genetic diversity of T. gondii isolates from Colombia. Recent studies, especially in the states of Antioquia, Quindío and Cundinamarca, indicate that toxoplasmosis is a major public health problem. Approximately half of the women of child bearing age have T. gondii antibodies, and the clinical disease in congenitally infected children is more severe than in Europe. Limited studies indicate that the strains of T. gondii from Colombia are genetically and phenotypically different than in Europe and North America. However, epidemiological factors, such as the involvement of domestic and/or wild animals in transmission, the distribution of strain diversity by natural geographic regions, and the variation in risk factors between regions that are associated with human infection in Colombia, remain unknown. Areas of research for the future are outlined. This review should be of interest to biologists, veterinarians, physicians, and parasitologists.

Keywords

Colombia Epidemiology Toxoplasma gondii Toxoplasmosis Congenital Ocular Genotypes Public health Outbreaks

Review

Toxoplasmosis is a worldwide zoonosis with asymptomatic infections in most adult immunocompetent humans. Why some persons infected with Toxoplasma gondii become sick and even die is not completely understood. Recently, in French Guiana, immunocompetent adults died of toxoplasmosis[1]. In Brazil, a higher proportion of congenitally infected children developed severe disease and the onset of clinical symptoms was also earlier than such cases from the rest of the world[2].

Host and/or parasite factors play a pathogenic role. In addition, it has been hypothesized that the strains of T. gondii involved might influence the severity of toxoplasmosis[3]. Recent studies indicate that the strains of T. gondii from South America are phenotypically and genetically different from those in Europe and North America[4, 5]. Information obtained from studies in Brazil and some recent studies in Colombia indicate that a similar scenario might apply to both countries with severe clinical consequences in congenitally infected children.

Although Colombia has the third greatest human population of South America (47 million habitants) and harbors one of the highest biodiversities in the world[6], there is no systematic review of the literature for studies on toxoplasmosis. Here, we review toxoplasmosis in humans and animals from Colombia and highlight the need for further studies on toxoplasmosis as a real public health problem.

History and introduction

Historically, T. gondii was first found in a Colombia in a naturally infected guinea pig (Cavia porcellus)[7] but little else was known until Roca-García et al.[8] published the first detailed description of a case of congenital toxoplasmosis in a 40 day-old girl born to an apparently healthy mother from Bogota, Colombia. The child had classical Sabin’s tetrad symptoms of congenital toxoplasmosis including bilateral chorioretinitis, hydrocephalus, cerebral calcifications, jaundice, hepatomegaly and splenomegaly. T. gondii was isolated from the cerebrospinal fluid by bioassay in mice and the strain was found to be virulent for mice, guinea pigs, rabbits, chickens and pigeons. These authors provided an update of toxoplasmosis in children worldwide at that time[8].

The need for prenatal screening of women was recognized in 1970’s, and Restrepo et al.[9] made an initial attempt to screen 120 women. They found that half of the women were seronegative and 8.3% became seropositive during pregnancy; viable T. gondii was isolated from 10 of 30 placentas obtained from these women[9]. These observations eventually led to the first national serological study in the general population, in 1980, and then to a multicenter study of congenital toxoplasmosis[10].

Varela and Roca[11] performed the first serological survey in Indian Guambias in Cauca, Colombia by using the Sabin Feldman dye test (SF). Feldman[12], coauthor of the SF test, reported that T. gondii seroprevalence in Colombia was approximately four times that in the USA. He tested sera from military recruits and found that seroprevalence was 50% of 2,803 from Colombia, 56% of 2,023 from Brazil, and 14% 2,680 from the USA using the SF test. These findings are of historic importance because we are not aware of any other study where prevalence has been compared in humans (all males) of one age group from three countries by one laboratory using identical methodology.

The SF dye test is the most specific test for the detection of antibodies to T. gondii in humans and even low titers (1:4–1:16) are considered specific[13]. However, this test is technically difficult, hazardous to perform (because live virulent T. gondii are needed for the test), and not used now in Colombia or in most other countries. Since then, several other serological tests have been developed, and data based from other tests are not always comparable. We have summarized in Table 1 all serological tests used for studies in Colombia, so that readers can draw their own conclusions concerning the prevalence of T. gondii antibodies in humans and animals summarized throughout the review. Cut-off values are indicated in Tables wherever the authors provided the information.
Table 1

Technical features of serological tests used for detection of T. gondii antibodies in humans and animals in Colombia

Test, abbreviation

Antigens

Manufacturer

Tables referred

Sabin Feldman dye test, SF

Live tachyzoites

In-house

2, 3

Skin test

Soluble

In-house

2, 4

Indirect haemagglutination, IHAT

Soluble

Not stated

5

Indirect haemagglutination, IHAT

Soluble

Behringwerke, Germany (Note, these company have merged into CSL Behring) http://www.cslbehring.com

5

Indirect haemagglutination, IHAT

Soluble

Not state

2

Indirect fluorescent antibody, IFAT

Inactivated

Not stated

2, 3, 5

Indirect fluorescent antibody, IFAT

Inactivated

Cappel Laboratories, Cochranville PA, USA

5

Indirect fluorescent antibody, IFAT

Inactivated

CSL Behring, Germany http://www.cslbehring.com

2, 3

Indirect fluorescent antibody, IFAT

Whole formaldehyde- fixed tachyzoites

National Institute of Health, Santa fé de Bogotá, Colombia http://www.ins.gov.co

2, 3, 4, 5

Modified Agglutination, MAT

Formalin-treated whole tachyzoites

Biomérieux, Craponne, France http://www.biomerieux.com

5

Immunosorbent Agglutination Assay test, ISAGA

Whole tachyzoites-killed

Biomérieux, Craponne, France http://www.biomerieux.com

2

Enzyme linked fluorescent assay, ELFA VIDAS® EBV IgG, IgM

Soluble,

Biomérieux, Craponne, France http://www.biomerieux.com

2, 3, 4

Enzyme linked immunosorbent assay, ELISA

   

1. Micro ELISA

Soluble

Not stated

2, 4

2. TOXO IgG Detect ELISA Kit

Inactivated

BioKit, Barcelona, Spain http://www.biokit.com

2, 4

3. Toxoplasma ELISA IgG, IgM

Soluble

Vircell S.L., Grenade, Spain http://www.vircell.com

2, 3, 4

4. Plateia TOXO IgG, IgM

Whole tachyzoites

Bio-Rad, Marnes-la-Coquette, France http://www.bio-rad.com

2, 3, 4

5. Human® Toxo-IgG

Soluble

Human Biochemica und Diagnostica mbH, Wiesbaden, Germany http://www.human.de/de

2

MEIA Microparticle Enzyme Immunoassay, AxSYM Toxo IgG, IgM

Soluble

Abbott Laboratories, Illinois, USA http://www.abbott.com

2, 3, 4

Review methodology

Using the key terms “Toxoplasma [and] Colombia” and “Toxoplasmosis [and] Colombia” to search publications from 1944 to 2014, we queried PubMed, Medline, SciELO and Google Scholar. National and international scientific journals were systematically reviewed and originals of all papers were consulted. After excluding summaries of conference reports, 90 publications met our selection criteria, including original articles (64), clinical trials (5), case reports (19) and reviews (2).

Toxoplasmosis in humans

Seroprevalence and correlates of infection

Data are summarized in Tables 2,3 and4 and Figure 1.
Table 2

Studies of seroprevalence of T. gondii in human populations conducted in Colombia

Year

Population studied

Area on the map

No. tested

Test (cut-off)

No. positive (%)

Reference

Low risk groups

     

1956

Indigenous Guambianos

CAU

297

SF (16)

88(29.63)

[11]

1956

Healthy patients

D.C, BOL, ATL, CAL, ANT

36

SF (NR)

22(61.11)

[14]

1959

Healthy individuals

D.C

205

SF (NR)

47(22.93)

[14]

Mental patients

111

23(20.72)

Patients with diverse ailments

38

15(39.47)

1968

Blood donors

ANT

184

SF (2)

98(53.26)

[15]

1969

Patients from Tunja Hospital

BOY

171

SF (8)

41(24.00)

[16]

Soldiers

BOY

254

134(52.76)

1974

Soldiers from several regions

 

1771

SF (16)

886(50.02)

[12]

1976

Pregnant women

ANT

120

SF (NR)

10(8.33)

[9]

1980

Pregnant women, nationwide survey

 

414

IFAT (16)

26(63.04)

[17]

1992

Pregnant women (National Institute of Health)

D.C

1000

IFAT (16)

590(59.00)

[18]

1993

Pregnant women

QUI

1617

IFAT (16)

1024(63.33)

[19]

1996

Pregnant women

CAS

51

IFAT(16)

37(72.55)

[20]

Women of reproductive age

327

253(77.37)

1997

Pregnant women

QUI

937

IFAT (16)

569(60.73)

[21]

1998

Pregnant women

D.C

637

IFAT (16)

299(46.94)

[22]

2003

Individuals without contact with dogs

CAL

300

IFAT (64)

132(44.00)

[23]

Dog owners

306

99(32.35)

2005

Pregnant women

MET

300

ELISA (>10 UI/ml)

158(52.67)

[24]

2005

Pregnant women

VAC

955

MEIA (NR)

(45.76)

[25]

2007

University students without ocular lesion

QUI

21

ELISA (>10 UI/ml)

13(61.91)

[26]

University students with ocular lesion

12

9(75.00)

2008

Group volunteers

Not Stated

140

ELISA (>1 UI)

74(52.86)

[27]

2009

National Institute of Health of Colombia

D:C

243

ELISA (>10 UI/ml)

137(56.38)

[28]

2012

Adult and child population

NAR

240

ELISA (>9 UI/ml)

108(45.00)

[29]

High-risk groups

     

1981

Patients with clinical toxoplasmosis

VCA

44

IHAT (NR)

24(54.55)

[30]

1981

Handlers of slaughterhouses

ANT

169

IFAT (16)

45(26.63)

[31]

2001

HIV-positive patients

D.C

16

IFAT (128)

(93.75)

[32]

2003

Pregnant women with a history of abortion

SUC

100

ELFA (>8 UI/ml)

56(56.00)

[33]

2005

Patients with uveitis

D.C

25

ELISA (>9 UI/ml)

23(92.00)

[34]

2006

Veterinarians

MET

86

ELISA (>10 UI/ml)

36(44.19)

[35]

2007

HIV patients with cerebral toxoplasmosis

QUI

21

ELISA (>10 UI/ml)

16(76.19)

[36]

2008

Handlers in slaughterhouses

D.C,

82

ELFA (>8 UI/ml)

44(53.66)

[37]

SAN

73

48(65.75)

ANT

72

45(62.50)

COR

80

67(83.75)

MET

93

83(89.25)

2009

Soldiers operating in jungle

D.C

490

ELISA (NR)

394(80.41)

[38]

Urban soldiers operating in Bogotá

501

226(4511)

2011

Colombian newborn screening of Toxoplasma

QUI

1517

IC-ELISA (OD 8)

31(2.04)

[10]

ATL

2901

2(0.07)

D.C

5398

12(0.22)

SAN

3036

7(0.23)

NSA

1124

0(0.00)

CAQ

510

9(1.76)

 

LAG

801

 

0(0.00)

 

NR: not registered.

Table 3

Correlates of seroprevalence of T. gondii in human population in Colombia

Population studied (location)

No. tested

No. positive (%)

Correlates of infection

Reference

Healthy, mentally ill and other pathologies (Bogotá)

354

85 (24.0)

Patients with various disorders, >41 years old

[14]

Blood donors (Medellín)

184

98 (53.3)

16–30 years old

[15]

Pregnant women (Quindío)

1617

1024 (63.3)

Ownership and contact with cats, consumption of raw meat, 39 – 44 years old

[19]

Pregnant women (Villavicencio)

300

158 (52.5)

Contact with stray cats

[24]

Pregnant women (Cali)

955

437 (45.8)

30–39 years old, low socioeconomic level

[25]

Group volunteers Colombia – Italy

140

122 (50.8)

Age

[27]

Asymptomatic population (Manizales)

606

231 (38.1)

50–69 years old

[23]

Asymptomatic population (Pasto)

240

108 (45.0)

Adults, geographical differences, association with geohelminth infections

[29]

Handlers in slaughterhouses (Medellín)

169

45 (26.6)

Pig meat handlers 33–37 years old

[31]

Pregnant women with a history of abortion (Sincelejo)

100

56 (56.0)

Cat exposure

[33]

Handlers in slaughterhouses

400

287 (71.8)

Ingestion of raw meat, exposure to animals, contact with soil

[37]

Soldiers in operations in the Amazon rainforest (Bogotá)

1001

620 (61.9)

Geographical differences, untreated water consumption, consumption of wild meat

[38]

Colombian newborn screening of Toxoplasma

15.333

61 (0.39)

Rate of annual rainfall, geographical differences

[10]

Table 4

Incidence of toxoplasmosis on seroconversion or acute markers rates in different Serological studies in Colombia (1994–2014)

Population studied

Location

No. tested

Incidence (%)

Reference

Pregnant women

Medellin

120

8.3

[9]

Newborns

Bogotá

1320

1.4

[18]

Pregnant women

Armenia

896

1.3

[19]

Pregnant women

Quindío

933

1.6

[21]

Pregnant women

Sincelejo

100

2.0

[33]

Ophthalmic patients

Bogotá

25

12.0

[34]

Veterinarians

Villavicencio

86

4.6

[35]

Ophthalmic patients

Armenia

9

11.1

[26]

Pregnant women

Villavicencio

300

11.0

[24]

Pregnant women

Cali

995

2.8

[25]

Handlers in slaughterhouses

Bogotá

400

2.8

[37]

Bucaramanga

Medellin

Monteria

Villavicencio

Newborns (seven regions of the country)

Armenia

15333

0.5-6.2

[10]

Barranquilla

Bogotá

Bucaramanga

Cúcuta

Florencia

Rioacha

Asymptomatic population

Tuquerres

240

4.2

[29]

Tumaco

Figure 1

Serological studies of T. gondii infection in humans and animals in Colombia (1944–2014). On the map are indicated the natural regions and states of Colombia. I Caribbean Region: Archipelago of San Andrés and Providencia (SAP), La Guajira (LAG), Atlántico (ATL), Magdalena (MAG), Cesar (CES), Sucre (SUC), Bolívar (BOL), Córdoba (COR); II Pacific Region: Chocó (CHO), Valle (VAC), Cauca (CAU), Nariño (NAR); III Andean Region: Bogotá D.C (D.C), Norte de Santander (NSA), Antioquia (ANT), Santander (SAN), Risaralda (RIS), Caldas (CAL), Cundinamarca (CUN), Boyacá (BOY), Quindío (QUI), Tolima (TOL), Huila (HUI); IV Orinoquía Region: Arauca (ARA), Casanare (CAS), Vichada (VID), Meta (MET) and V Amazon Region: Putumayo (PUT), Caquetá (CAQ), Guaviare (GUV), Guainía (GUA), Vaupés (VAU), Amazonas (AMA).

There are several reports of T. gondii seroprevalence in the general human population, most of them based on convenience samples. A national study, using the indirect fluorescent antibody test (IFAT, cut-off 1:16), found an overall prevalence of 47.1% (4,304/9,139), with similar proportions in men (47.9%) and women (46.3%) and an increased risk of infection among pregnant women. They stated that seropositivity in 0–9 year old children was 32% (604 of 1,890) with similar prevalence in males (32.6%) and females (31.9%)[17]. The data in this report are difficult to interpret because, in most instances, only percentages of seropositivity are given without the number of subjects studied; there is a need for a new updated, population based study.

Data collected with respect to correlates of infection are also summarized in Table 3.

Handlers in slaughterhouses in Colombia were characterized as an occupational risk group[31, 37, 39], whereas this association was not established in Villavicencio veterinarians[35]. The presence of cats, geographical differences[17], age, environmental exposure, co-infection with Ascaris lumbricoides[29], sociocultural characteristics[27], educational level[40], untreated drinking water and ingestion of meat from wild animals[38] are epidemiological factors that have been associated with human toxoplasmosis in Colombia. Unrelated factors included physical condition[14], gender, consumption of undercooked pork[23], socio-demographic conditions[40] and altitude[12].

Various mathematical models of transmission dynamics of T. gondii in Colombia suggest a synergy between endemic levels of infection between cats and humans[41]. Consequently, the control of the feral feline population would have a significant effect on parasite dispersion by reducing environmental contamination by oocysts[42]. However, controlling the feral cat population does not interrupt T. gondii propagation[43] because of the proximate relationship between inoculum and infection[44], which is increased by the dispersion of T. gondii oocysts in water, which can even reach locales without a definitive host[45].

Post-natally acquired infections

Little is known of clinical toxoplasmosis in the general population. Toxoplasmosis associated pneumonia was reported in a 26 year old[46], and nephritis in a 15 year old male[47].

Restrepo[48] mentioned a foodborne outbreak of toxoplasmosis. Lymphadenopathy and fever were observed in 11 of the 30 persons who participated in a barbecue where pork was the main food offered in 2005 in Jericó, Antioquia. Affected people became sick 10 to 15 days after the party and they were stated to have IgM T. gondii antibodies, but no other details were given. Thus, critical evidence concerning diagnosis is missing and it is unfortunate that these findings were mentioned in passing.

A waterborne outbreak of toxoplasmosis was reported in 18 individuals, 24 to 33 year old male Colombian soldiers deployed in a remote area in La Macarena, Meta. All patients had cervical lymphadenopathy, one had myocarditis, one had pneumonia, and one had diarrhea. All patients had high (>1024) IgM and IgG T. gondii antibodies. They were hospitalized, treated with pyrimethamine, sulfadoxine, and clindamycin, and all recovered. Drinking water contaminated with oocysts was thought to be the source of infection[49].

A well planned epidemiological investigation revealed that 80% of 501 Colombian soldiers operating in a jungle were seropositive to T. gondii and four (0.8%) had chorio-retinal lesions compared with 45% seropostivity in 501 soldiers deployed in urban Bogota, and only one (0.19%) had chorioretinitis. Drinking water was considered to be the source of higher seropositivity in jungle deployed soldiers[38].

Pregnancy and congenital disease

Initial studies concerning acquired toxoplasmosis during pregnancy reported rates of 1.3% to 8.4% in different regions of Colombia (Table 4). Regardless of geographical region, the proportions were similar in studies based on double increase of IgG levels (by ELISA or IFAT technique) or with specific detection of IgM and IgA antibodies (Tables 2 and4).

The national multicentric study revealed that the incidence of congenital toxoplasmosis was not homogenous, with significant variations between regions as well as a strong association among high mean annual rainfall (3,840-2,500 mm/year) and frequency of toxoplasmosis in women during pregnancy (3-6%). In addition, a mean of congenital infection was estimated for Colombia as one of 1,000 newborns (15 confirmed cases between 15,000 children studied); hence with a population of 550,000 newborn per year in the nationwide (Table 5), it is expected about 550 infected newborns per year[10].
Table 5

Clinical toxoplasmosis in congenitally-infected children in Colombia

Reference

Location

Type of sample

No. tested

Infected (%)

Sex (%)

Deaths (%)

Neurological symptoms and signs (%)

Ocular symptoms and signs (%)

Hepato-splenomegaly (%)

Prematurity (%)

1981[30]

Cali

Referred cases (1955–1975), confirmed by necropsy (21 cases) or with serological studies

44

NA

Male 25 (56.8)

21 (47.7)

Microcephaly and cerebral calcifications: 30 (68.1)

25 (56.8)

27 (62.5)

8/16 (50.0)

1983[50]

Medellin

Referred cases confirmed by IFAT test

27

NA

Male 17 (63.0)

NR

Microcephaly: 20 (74.0) Neurological psicomotor deficit: 22 (81.5) Electroencephalogram changes: 8/14 (57.0)

Strabismus: 9 (33.0) Cataract: 1 (3.7) Chorioretinitis 11(40.7)

8 (29.0)

5 (18.5)

1997[21]

Quindío

Children prenatal screening

15

1/15 (6.7)

Female

NR

NR

Chorioretinitis (6.7)

NR

NR

2000[51]

Bogota Armenia

Referred cases confirmed by IFAT and ISAGA test

27

NA

NR

1 (3.7)

Calcification, hydrocephaly or microcephaly: 12 (44.4)

Chorioretinitis 11 (40.7)

16 (59.0)

5 (18.5)

2005[52]

Armenia

Children prenatal or newborn screening

26 (17 by screening and 11 symptomatic)

NA

NR

2 screened <6 mo. of age (11.7%) 1 of 11 symptomatic (9%).

17 screened 4 of 11 symptomatic (36%)

13 screened 4 symptomatic (30%)

26 screened 7 symptomatic (26.9%)

NR

2006[53]

Quindío

Newborn screening in referral hospital

200

1/200 (0.5)

Female

1 (Respiratory distress syndrome)

NR

NR

NR

NR

2007[54]

Quindío

Newborn screening in community hospitals

322

2/322 (0.5)

NR

NR

NR

NR

NR

NR

2011[10]

Armenia Barranquilla Riohacha Cucuta Bogota BucaramangaFlorencia

National multicentric newborn screening

15,333

218 (1.4) by criteria for confirmation assays (109; 50% by confirmatory assays; 15 (13.7%) by congenital infection and 3/15 newborns with prenatal treatment

NR

3/15 (20.0)

4/15 (26.6) calcifications; 1/15 (6.6) hydrocephaly

3/15 (20.0) chorioretinitis

1/15 (6.6) splenomegaly

1/15 (6.6)

NA: not applicable; NR: not registered.

Colombian gynecologists currently use molecular methods to determine the fetal transmission of T. gondii. DNA of T. gondii was detected in 10.1% of amniotic fluid by amplification of the B1 gene in positive samples of mothers with serological criteria for acute toxoplasmosis in Bogotá[55]. PCR on maternal blood samples is not a confirmatory test of fetal infection; nevertheless, a PCR-B1 assay described a positivity of 12% in blood samples of positive pregnant women from Sincelejo[56]. Moreover, a serologic test (ELISA ELFA) showed in the same location seroconversion of 2% during gestational control and neonatal mortality[33] and exposed the burden of congenital toxoplasmosis in the Caribbean region.

As mentioned in the introduction, the severity of congenital toxoplasmosis has been recognized in Colombia since 1949, when the first case was diagnosed and reported in 1951[8, 30, 5153]. Ophthalmic complications also have been reported as strabismus and bilateral chorioretinal scars[57], hydranencephaly[58], vitreous hyper-echogenicity, severe hydrocephalus[59] and neuro-ophthalmic infection[60].

Because until now there was no planned T. gondii screening program to follow pregnant women and infected children, the information on clinical toxoplasmosis in children in Colombia is fragmentary. Here, we attempted to summarize available information in Table 5. Although these reports were based on sporadic cases from Colombian referral centers, it is likely that the apparent clinical severity is associated with geographical differences. Indeed, the multicenter study[61], with 25 cohorts of infected mothers from Europe, North America, and South America, provided unexpected results and concluded that ocular risk (47%) and intracranial lesions (53%) among Colombian children far exceeded that of European children (14% and 9% respectively).

There is no depository of T. gondii isolates from Colombia. One T. gondii isolate (designated CIBMUQ/HDC) from blood of a congenitally infected child in Quindío, Armenia has been deposited in the French National Collection[62]. The infected child was born to a 13-year old mother when she was in the 33 week of gestation. The child had hepato-splenomegaly and icterus. Viable T. gondii was isolated from the peripheral blood buffy coat of the child by bioassay in mice and cell culture. The strain was mouse-virulent and genotype I (see section on genotyping).

In Colombia, risk factors associated with congenital infection are contact with cats[24, 33], spatial dispersion of T. gondii by domestic cats[44], eating undercooked meat or ingesting untreated water[63], living in households in marginal areas, socio-economic status[25] and geographic differences and rainfall[10] (Table 3).

Ocular disease

In Cali, the Institute for Deaf and Blind Children lists toxoplasmic chorioretinitis as the second leading cause of congenital blindness[64], and it is the third leading cause according to the ophthalmologic evaluation of infants under 16 years of age (19/127), affecting a higher proportion of girls between six months and six years of age (63.2%)[65], and three cases of ocular toxoplasmosis occur per 100,000 inhabitants in Quindío[66].

Chorioretinal lesions were diagnosed in patients from rural and urban areas of Bogotá[34], and in 6% (12/200) of the student population of the University of Quindío[26]. Posterior uveitis (67.2%), panuveitis (46.6%) and unilateral (79.0%) lesions were observed in 39.5% (109/276) in two Colombian referral centers in Quindío and Bogotá[67]. Active lesions (45.0%) and recurrent retinochoroiditis (59.3%) are responsible for decreased visual acuity in 60.5% of cases with remarkable visual dysfunction in bilateral condition[68].

In recurrent ocular toxoplasmosis, atypical uveitis is the most common complication[69]. Episodes of recurrence can occur at approximately 11 year intervals and are associated with the presentation of inactive chorioretinal lesions and antibiotic therapy without accompanying steroid treatment[70].

Immunocompromised patients

An estimated 7,000 to 10,000 new cases of toxoplasmosis in positive HIV patients occur annually in Colombia[71], with cerebral toxoplasmosis (CT) as the main complication. Toxoplasma seropositivity was recorded in patients from Bogotá (15/16 cases)[32] and in 54 cases from Cúcuta, with a post-diagnosis survival of 50%[72]. In a study of 821 autopsies in one hospital in Santander from 2004–2007, T. gondii –associated lesions and parasites were found in 17 (28.3%) of 60 cases of HIV infected persons[73] and a single case report in Huila[74]. Brain tomography, IgG antibody detection, detection of T. gondii DNA in peripheral blood are considered effective for the diagnosis of CT[36, 75].

CT shows effects on consciousness, neural disorders and orientation[36] and complications may occur, including chorioretinitis with opacity of the optic nerve[76], and infection of the spinal cord with involvement of lower limb motor function; T. gondii tachyzoites were identified immunohistochemically in biopsy of the thoracic spinal cord[77].

Toxoplasmosis in animals

Clinical

Four months after a flock of Blackface sheep imported from Great Britain disembarked in Colombia, premature births and abortions occurred within the first 48 hours after birth; bioassays in mice and the histopathological analysis of fetal and placental products identified T. gondii, and 44 females tested positive by indirect hemagglutination tests[78]. It was speculated that ewes might have become infected with T. gondii during prolonged quarantine, and stress of transportation in Great Britain during transit to Colombia might have caused abortion.

As part of rabies surveillance, brains of animals suspected to have rabies from 1967–1972 were examined for Negri bodies and by mouse inoculation: T. gondii was found in 2 of 235 cats, 8 of 772 dogs, 3 of 93 rats and 1 of 1 guinea pig[79]. The clinical significance of these findings is uncertain.

We are not aware of any other reports of clinical toxoplasmosis in Colombia.

Serological and parasitological prevalence

Data are summarized in Tables 6,7 and Figure 1.
Table 6

Seroprevalence studies of T. gondii in domestic animals in Colombia

Year

Area on the map

Species

Number

Serologic test (cut-off)

No. positive (%)

Reference

1965

D.C

Dogs

1000

SF (8)

157 (15.7)

[80]

2003

CAL

 

306

IFAT (32)

124(40.5)

[23]

2007

D.C

 

309

MAT (20)

52(16.8)

[81]

1970

ANT

Cats

181

SF(8)

112(61.9)

[15]

2006

QUI D.C

 

25137

MAT (20)

21(84.0) 31(21.3)

[82]

2006

CAL

Horses

777

IFAT (32)

164(21.1)

[83]

1981

ANT

Pigs

368

HIA (64)

111(30.2)

[84]

2006

CAL

 

797

IFAT (32)

122(15.3)

[83]

1981

ANT

Cattle

371

HIA (64)

90(24.3)

[84]

1981

ANT

 

361

IFAT (16)

108(29.9)

[31]

2006

CAL

 

397

IFAT (32)

140(35.3)

[83]

2005

QUI

Backyard chickens

77

MAT (20)

25(32.4)

[85]

2006

CAL

 

955

IFAT (64)

149(15.6)

[83]

1978

BOY

Sheep

1141

IHAT (16)

724(63.5)

[86]

CES

46

30(65.2)

LAG

145

86(59.3)

HUI

96

34(35.4)

NAR

130

59(45.4)

 

NSA

 

97

 

25(25.8)

 
Table 7

Isolation of viable T. gondii from tissues of animals in Colombia

Host

Region

Type

No. bioassayed

Tissues bioassayed

No. positive

Mouse virulencea

T. gondii isolate designation

Reference

Chicken

Quindío

Free range

72

Heart, brain

23

16

TgCkCo1-23

[85, 87]

Cat

Armenia Bogotá

Unwanted

116

Heart, brain

15

9

TgCtCo1-15

[82, 87]

Dog

Bogotá

Unwanted

37

Heart, brain, tongue

20

4

TgDgCo1-20

[81]

a100% mortality in outbred mice.

Cats

Seroprevalence in cats deserves special attention because of the epidemiological importance as definite host of T. gondii. Jewell et al.[15] surveyed people and pet cats from Medellin; 112 (62%) of 181 cats had dye test antibodies with titers of 8 in 16, 32 in 34, 128 in 38, and 512 in 24 cats. Montoya et al.[88] reported IFAT antibodies in 25 of 28 cats from the city of Armenia, but little else was said of the cats surveyed nor of the IFAT titer. Dubey et al.[82] reported T. gondii antibodies in 52 (30.5%) of 170 cats with titers of 1:20 in 10, 1:40 in 7, 1:80 in 4, 1:160 in 8, 1:320 in 6, and 1:640 in 17. Thus, most of the cats had high titers; 21 (84%) of 25 cats from Armenia were seropositive compared with 31 (21.3%) from Bogota. Viable T. gondii was isolated from tissues of 15 of 42 cats with MAT titers of 1:40, but not from any of the 90 cats with titers of 1:20 or lower.

As of yet, viable T. gondii oocysts have not been demonstrated in cat feces in Colombia. Oocysts were not found by microscopic examination or by bioassay of feces of the 170 cats from Armenia and Bogota[82]. Montoya et al.[88] found T. gondii-like oocysts in 18 of 28 cats from Armenia, but there is no evidence to judge the validity of the findings. Herrera et al.[89] said that they isolated T. gondii from the feces of a cat but there is no other information about the cat and method of isolation. With respect to the demonstration of T. gondii oocysts, bioassay is essential because there are other T. gondii-like parasites in cat feces[13].

Food animals as sources of infection

Poultry, beef, pork and mutton are the most important sources of meat consumed by humans in Colombia. Only limited information is available concerning the prevalence of T. gondii in food animals (Table 6). Two surveys that were performed more than 30 years ago indicated a high prevalence of antibodies in cattle in Medellin (Table 6). A relatively recent study reported 140 (35.3%) of 397 cattle from Manizales were seropositive using a cut-off of 1:32 in the IFAT[83]. Cattle are considered a poor host for T. gondii and it is extremely rare to isolate viable T. gondii from beef[13]. Moreover, several serological tests, including the IFAT and IHAT used give a false positive unless the cut-off is high[13]. Thus, the role of beef in the epidemiology of T. gondii is uncertain.

A high prevalence (57.9%) of antibodies was recorded in sheep in six regions of the country (Table 6), but this study was done more than 35 years ago[86]. T. gondii infections in pigs had been recorded in 1979 and 1981 but these are also old studies[90, 91]. More recently, T. gondii antibodies were found in 15.3% of 797 > 8 months old pigs from Caldas[83]. The same study reported T. gondii antibodies in 15.6% of 955 chickens. There is no information with respect to T. gondii infection in goats used for meat.

Currently, there is a great public interest in food safety and the presence of viable T. gondii in meat. Serological surveys from slaughtered animals and the detection of parasite DNA in meat do not provide a true assessment of risk to humans because conditions for storage and treatment of meat from the time of slaughter and consumption affect the viability of parasites. Therefore, studies are needed to detect the presence of viable T. gondii in meat from retail meat markets. Lora et al.[92] found T. gondii DNA by PCR in 95 (52.7%) of 180 (60 samples each) meat samples (42 pork, 29 beef, 24 chicken meat). This is an alarming rate of contamination of meat samples from retail stores and needs confirmation.

Contamination of the environment with T. gondii

There are no specific data on the contamination of the soil and the environment with T. gondii oocysts in Colombia. However, the high seroprevalence of T. gondii in cats suggests that the environment is likely to be contaminated, because cats that are seropositive have shed oocysts[13]. Although T. gondii oocysts are shed for only 1–2 weeks in the life of the cat, millions of oocysts can be shed and they can survive outdoors for months.

Seroprevalence of T. gondii in free range chickens (small farms) is more indicative of soil contamination, because chickens feed from the ground, than as a food source for the main population. Seroprevalence in 77 free range chickens from 9 farms was 32.4%, using a MAT titer of 20, and viable T. gondii was isolated from 15 of the seropositive chickens[85]. Seropositive chickens were found on all properties, indicating widespread soil contamination in rural Quindío, Colombia.

The high seroprevalence of T. gondii in herbivores (Table 6) also indicates that the rural environment is also contaminated with oocysts. For example, the ingestion of oocysts is the main mode of transmission of T. gondii in sheep.

Dogs have been used as sentinel animals for estimating T. gondii infection in the environment because of their close contact with humans. Actually, dogs were found to be risk factor for T. gondii infection in people in Panama[93]. Dogs are known to eat cat feces and roll over in cat feces. Thus, their fur becomes contaminated with oocysts and children can become infected by petting infected dogs. In dogs, the prevalence for T. gondii was recorded in Bogota and Manizales; gender, age, race and type of feeding showed no significant correlation[23, 81, 91].

Recently, attention has been drawn to the prevalence of T. gondii in bats and epidemics of bat mortality. Most bat species are insectivores and live in caves. Thus, infection in these bats indicates contamination of caves by oocysts. In this respect, two of 38 Artibeus lituratus bats captured in Tibú, Santander had dye test antibodies[16].

Genetic characterization of T. gondii strains from Colombia

Information on genetic typing is summarized here. The quality of DNA is important for genetic typing and complete data can be obtained only from DNA extracted from large numbers of viable parasites, usually cell or mouse-cultured organisms. More limited information can be obtained on DNA extracted directly from tissues of asymptomatic animals. Humans become infected with T. gondii mostly by consumption of uncooked meat or the oocysts. Therefore, information on genotypes of isolates from animals, especially cats, is relevant to human infections.

Different methods have been used to type the isolates. Earlier information was obtained using serotyping[94] and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) with only SAG2 marker[85, 95]. Gallego et al.[95] detected T. gondii DNA in 50 of 146 samples from humans and animals but did not identify the samples of each species tested. Of the 50 PCR-positive samples, they characterized 33 samples using the SAG2 gene; 14 human samples (6 congenital infection, 3 HIV patients, 1 ocular toxoplasmosis, 3 pregnant women, 1 case of myositis), 2 Myarchus cephalotes, 15 cats (8 brains, 6 hearts, 1 fecal sample), 1 Didelphis marsupialis, and 1 guinea pig. It is really unfortunate that details of hosts and samples were not stated. By using the SAG2 gene, 31 of 33 samples were genotype SAG2 type I. Now we know that SAG2 typing in strains from South America is insufficient because of the polymorphic nature of the strains in this region need multilocus analysis. One of these strains (CIBMUQ/HDC) from the congenitally infected child was subsequently typed using six microsatellite markers (TUB2, TgM-A, W35487, BM189462, BM175053, N82375) and it was found to be type I; it is mouse virulent[62].

We have recently genotyped 53 isolates of T. gondii from cats, dogs, and chickens from Colombia using 11 RFLP markers (Tables 7,8). Nineteen genotypes were obtained, out of which only two were clonal and both of these were type I (Table 7). Type I strains are extremely rare worldwide. Thus, finding three Type I strains out of 54 isolates from Colombia suggests the need for further study.
Table 8

Genotypes of T. gondii from cats, dogs, chickens from Colombia based on 11 RFLP markers [87]

Toxo DB typea

No. of isolates

Designation

9, (Chinese1)

1

TgDgCo4

10 (Type I)

2

TgCtCo 2, 7

14

6

TgDgCo9,12,15,18; TgCkCo2;TgCtco14

18

3

TgCtCo 12, 13; TgDgCo3

23

1

TgDgCo19

28

2

TgCtCo 1; TgCkCo5

29

5

TgDgCo1,2,10,20; TgCkCo20

38

13

TgCkCo6,8,10,12,13,15,21,23,24; TgCtCo 4,10,11; TgDgCo17

40

1

TgCtCo5x

44

3

TgDgCo5,6,11

46

3

TgDgCo8,14,16

61

2

TgCtCo 5,6

62

2

TgCtCo3,9

79

1

TgDgCo13

101

1

TgCtCo15

122

1

TgDgCo7

128

1

TgCtCo8

178

1

TgCkCo4

179

2

TgCkCo17,22

188

1

TgCkCo9

Before the discovery of the methods to genotype, T. gondii strains were grouped as virulent or avirulent for mice. Howe and Sibley[96] proposed that T. gondii isolates can be grouped in to three types (I, II, III) based on RFLP typing, and that most strains were clonal. Additionally, Type I strains were 100% lethal for mice, whereas Types II and III were less pathogenic. Recent studies have shown that T. gondii isolates are genetically diverse, particularly those from Brazil and Colombia[4]. Now more than 200 genotypes of T. gondii are known; most of these are from South America, and there is an International Toxoplasma data base (http://www.toxodb.org) to record the different genotypes. Here, we have used the ToxoDB to record genotypes from Colombia (Table 8).

Additionally, T. gondii isolates from Colombia and Brazil were phenotypically different; 80% of T. gondii strains from Colombia were 100% lethal to outbred mice (Table 7), but only two were not Type I.

Currently, there is great scientific interest in finding the molecular basis of pathogenicity of T. gondii isolates. Now several genes, including ROP18, are found associated with virulence, but mouse virulence may not apply to all hosts[97].

As stated earlier, most of the T. gondii virulence studies have focused on infections in mice. Recently, scientists in Colombia have attempted to correlate severity of clinical toxoplasmosis in patients with genetic make of the strain and host responses (cytokine production), and found that the virulent allele of T. gondii ROP18 in ocular toxoplasmosis was correlated with severe ocular inflammatory response[98]. This study additionally found that the cytokine profile in Colombian patients with ocular toxoplasmosis was deviated to a Th2 profile[99]; instead, French patients had a Th1 preferential response[100]. Altogether, these results indicate that some Colombian strains cause more severe ocular toxoplasmosis due to an inhibition of the protective effect of IFN-γ. These findings afford new research avenues to revert the Th2 deviated immune response in patients with severe forms of ocular toxoplasmosis.

Conclusions and perspective

From the information summarized here, it is evident that the toxoplasmosis is a major public health problem and more than half of the women of child bearing age are seronegative for T. gondii and at risk of exposure to Toxoplasma during pregnancy and congenital transmission to their fetuses. Additionally, the clinical disease in congenitally infected children is more severe in Colombia than in Europe. It is tempting to speculate that severity of toxoplasmosis in children is, in part, related to unusual genetic types of T. gondii circulating in Brazil and Colombia. However, only one strain of T. gondii from a congenitally infected child from Colombia has been genotyped. Although most studies on toxoplasmosis in Colombia are limited to one region, studies during prenatal and newborn programs with adequate follow up of children are needed in order to ascertain the extent of clinical damage to children and to correlate with strain genetic typing. Evaluation of the current official, evidence-based guidelines will be needed to evaluate the impact on reducing the burden and sequelae of congenital infection. Little is known of sources of infection with T. gondii in humans and animals in Colombia. The level of contamination of the environment by oocysts and the percentage of food animals infected with viable T. gondii is also unknown. Colombia has vast rural areas and diverse wildlife. Virtually, nothing is known of the role of wildlife in the circulation of T. gondii.

Declarations

Acknowledgments

The authors thank Edilson de Oliveira Bernardino and Marcia Pereira de Miranda, Bibliographical Sector Switching, University of São Paulo, Brazil for bibliographical support and Bruna Pinto by map designer (http://www.behance.net/mapastcc), and Dr. Chunlei Su for his advice regarding genetic typing data in Table 8. The senior author (WAC-F) is recipient of postdoctoral fellowship funding (process number 2012/25180-9) Fundação de Apoio à Pesquisa do Estado de São Paulo/São Paulo Research Foundation, Brazil.

Authors’ Affiliations

(1)
Departamento de Medicina Veterinária Preventiva e Saúde Animal, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo
(2)
Laboratorio de Parasitología Veterinaria, Departamento de Salud Animal, Facultad de Ciencias Agropecuarias, Universidad de Caldas
(3)
Grupo de Estudio en Parasitología Molecular (GEPAMOL), Centro de Investigaciones Biomédicas, Universidad del Quindío
(4)
United States Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal Parasitic Diseases Laboratory

References

  1. Carme B, Demar M, Ajzenberg D, Dardé ML: Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis. 2009, 15: 656-658. 10.3201/eid1504.081306.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Dubey JP, Lago EG, Gennari SM, Su C, Jones L: Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012, 139: 1375-1424. 10.1017/S0031182012000765.View ArticlePubMedGoogle Scholar
  3. Robert-Gangneux F, Dardé M-L: Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012, 25: 264-296. 10.1128/CMR.05013-11.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Su C, Khan A, Zhou P, Majumdar D, Ajzenberg D, Dardé M-L, Zhu X-Q, Ajiokag JW, Rosenthalh BM, Dubey JP, Sibley LD: Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc Natl Acad Sci USA. 2012, 109: 5844-5849. 10.1073/pnas.1203190109.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Shwab EK, Zhu X-Q, Majumdar D, Pena HFJ, Gennari SM, Dubey JP, Su C: Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology. 2014, 141: 453-461. 10.1017/S0031182013001844.View ArticlePubMedGoogle Scholar
  6. Ceballos G, Ehrlich PR: Global mammal distributions, biodiversity hotspots, and conservation. Proc Natl Acad Sci USA. 2006, 103: 19374-19379. 10.1073/pnas.0609334103.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Patiño CL, De Zulueta J, Toro G: Toxoplasma (Caviae) en Colombia. Revista de la Facultad de Medicina. 1956, 24: 737-742.Google Scholar
  8. Roca-García M, Camacho-Gambá J, Esguerra GG: Un Caso de toxoplasmosis congenita. Rev Colomb Pediatr Pueric. 1951, 10: 238-289.PubMedGoogle Scholar
  9. Restrepo M, Jaramillo V, Kurzer A: Infección por Toxoplasma gondii durante el embarazo. Ant Med. 1976, 26: 347-353.Google Scholar
  10. Gómez-Marín JE, De-la-Torre A, Ángel-Muller E, Rubio J, Arenas J, Osorio E, Núñez L, Pinzón L, Méndez-Córdoba LC, Bustos A, De-la-Hoz I, Silva P, Beltrán M, Chacón L, Marrugo M, Manjarres C, Baquero H, Lora F, Torres E, Zuluaga OE, Estrada M, Moscote L, Silva MT, Rivera R, Molina A, Najera S, Sanabria A, Ramírez ML, Alarcón C, Restrepo N: First Colombian multicentric newborn screening for congenital toxoplasmosis. PLoS Negl Trop Dis. 2011, 5: e1195-10.1371/journal.pntd.0001195.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Varela G, Roca E: Encuesta serológica de toxoplasmosis practicada entre indios guambias de Colombia. Rev Inst Salubr Enferm Trop. 1956, 16: 51-55.PubMedGoogle Scholar
  12. Feldman HA: Toxoplasmosis: an overview. Bull N Y Acad Med. 1974, 50: 110-127.PubMed CentralPubMedGoogle Scholar
  13. Dubey JP: Toxoplasmosis of Animals and Humans. 2010, Boca Raton, Florida, USA: CRC PressGoogle Scholar
  14. Muñoz-Rivas G: Toxoplasmosis en Colombia. Rev Inst Salubr Enferm Trop. 1959, 19: 351-355.Google Scholar
  15. Jewell ML, Thompson DP, Frenkel JK: Toxoplasmosis: Títulos de anticuerpos en humanos y gatos domésticos de Medellín, Colombia. Antioquía Med. 1973, 23: 145-152.Google Scholar
  16. De Roever-Bonnet H, Lelyveld J, Marinkelle CJ: Toxoplasmosis in Latin-American countries. Trop Geogr Med. 1969, 21: 451-455.PubMedGoogle Scholar
  17. Juliao RO, Corredor AA, Moreno MGS: Estudio Nacional de Salud: Toxoplasmosis en Colombia. Ministerio de Salud. Bogotá, Imprensa Instituto Nacional de Salud. 1983, 67-Google Scholar
  18. Santacruz MM, Heredia R, Corredor AA: Efecto de medidas preventivas contra la toxoplasmosis en embarazadas. Biomed. 1992, 12: 61-67. 10.7705/biomedica.v12i2.2024.View ArticleGoogle Scholar
  19. Gómez JE, de Londoño MT, Castaño JC, Pérez JC, Ríos MP: Epidemiología de la infección por Toxoplasma gondii en gestantes de Armenia, Quindío, Colombia. Colom Med. 1993, 24: 14-18.Google Scholar
  20. Posada VMP, Osorio EEJ, Alvarez MCA, López C, Moncada LI, Cáceres E, Agudelo CA, Corredor AA: Seroprevalencia del Toxoplasma gondii en mujeres consultantes al Hospital de Yopal. Casanare 1996. Rev Fac Med UN Col. 1997, 45: 128-131.Google Scholar
  21. Gómez-Marín JE, Montoya-de-Londoño MT, Castaño-Osorio JC: A maternal screening program for congenital toxoplasmosis in Quindío, Colombia and application of mathematical models to estimate incidences using age-stratified data. Am J Trop Med Hyg. 1997, 57: 180-186.PubMedGoogle Scholar
  22. Barrera AM, Castiblanco P, Gómez MJE, López MC, Ruiz A, Moncada L, Reyes P, Corredor A: Toxoplasmosis adquirida durante el embarazo, en el Instituto Materno Infantil en Bogotá. Rev Salud Publica. 2002, 4: 286-293.Google Scholar
  23. Aricapa GHJ, Pérez CJE, Cardona JM, Piedrahita A: Seroprevalencia de toxoplasmosis humana y canina en el municipio de Manizales, año 2003. Biosalud. 2005, 14: 9-17.Google Scholar
  24. Castro AT, Góngora A, González ME: Seroprevalencia de anticuerpos a Toxoplasma gondii en mujeres embarazadas de Villavicencio, Colombia. Orinoquia. 2008, 12: 91-100.Google Scholar
  25. Rosso F, Les JT, Agudelo A, Villalobos C, Chaves JA, Anais TG, Messa A, Remington JS, Montoya JG: Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America. Am J Trop Med Hyg. 2008, 78: 504-508.PubMedGoogle Scholar
  26. De-la-Torre A, González G, Díaz-Ramírez J, Gómez-Marín JE: Screening by ophthalmoscopy for Toxoplasma retinochoroiditis in Colombia. Am J Ophthalmol. 2007, 143: 354-356. 10.1016/j.ajo.2006.09.048.View ArticlePubMedGoogle Scholar
  27. Pordeus V, Barzilai O, Sherer Y, Raggio LR, Blank M, Bizarro N, Villalta D, Anaya J-M, Shoenfeld Y: A latitudinal gradient study of common anti-infectious agent. Antibody prevalence in Italy and Colombia. Israel Med Assoc J. 2008, 10: 65-68.Google Scholar
  28. Cortés LJ, Mancera L: Concordancia entre ElISA e RIFI para la determinación de anticuerpos tipo IgG contra Toxoplasma gondii. Infectio. 2009, 13: 76-82. 10.1016/S0123-9392(09)70728-3.View ArticleGoogle Scholar
  29. Ek C, Whary MT, Ihrig M, Bravo LE, Correa P, Fox JG: Serologic evidence that Ascaris and Toxoplasma infections impact inflammatory responses to Helicobacter pylori in Colombians. Helicobacter. 2012, 17: 107-115. 10.1111/j.1523-5378.2011.00916.x.PubMed CentralView ArticlePubMedGoogle Scholar
  30. Chamorro-Mera C, Hurtado LM, Angel AE: Toxoplasmosis. Aspectos clínicos, radiológicos y patológicos. Presentación de 44 casos. Colomb Med. 1981, 12: 61-74.Google Scholar
  31. Villa R, Gaviria I, Alzate F, Cañas L, Montoya F: Niveles de anticuerpos para Toxoplasma gondii por inmunofluorescencia indirecta. Acta Med Colomb. 1981, 6: 225-234.Google Scholar
  32. Gómez-Marín JE, Alvarado F, Hernández C, Cuervo S, Saravia J: Tratamiento de la fase aguda de la toxoplasmosis cerebral con Clindamicina - Falcidar (Pirimetamina-Sulfadoxina) en pacientes infectados por VIH. Infectio. 2001, 5: 162-168.Google Scholar
  33. Machado TNP, Manrique CEE, Ruiz HBM, Blanco TPJ: Alta frecuencia de seroconversión toxoplásmica en gestantes de Sincelejo-Sucre. Infectio. 2004, 8: 263-267.Google Scholar
  34. Hernández RP, Quintero G, Escobar M, Molano S, Mesa D: Estudio serológico de infección ocular por Toxoplasma gondii en pacientes que conviven o no con animales. Cienc Tecnol Salud Visual Ocul. 2005, 4: 59-67.Google Scholar
  35. Oyola LM, Martínez WH, Góngora A, Parra JL: Encuesta seroepidemiologica transversal a Toxoplasma gondii en médicos veterinarios del municipio de Villavicencio, Meta. Revista Orinoquia. 2006, 10: 50-56.Google Scholar
  36. Castaño-Osorio JC, Sánchez VG, Franco-Andrew D, González SMM, Giraldo-García AM: Determinación de las características clínico-epidemiológicas de la neuroinfeccción en pacientes con diagnóstico de VIH/sida en el departamento del Quindío. Infectio. 2007, 11: 173-182.Google Scholar
  37. Montealegre SIA, Valbuena YA, Cortés LJ, Flórez SAC: Seroprevalencia de la toxoplasmosis y factores relacionados con las enfermedades transmitidas por alimentos en trabajadores de plantas de beneficio animal en cinco ciudades capitales de Colombia, 2008. NOVA. 2009, 7: 66-70.Google Scholar
  38. Gómez-Marín JE, De-la-Torre A, Barrios P, Cardona N, Alvarez C, Herrera C: Toxoplasmosis in military personnel involved in jungle operations. Acta Trop. 2012, 122: 46-51. 10.1016/j.actatropica.2011.11.019.View ArticlePubMedGoogle Scholar
  39. Romero PMH, Sánchez VJA, Hayek PL: Leptospirosis, brucelosis y toxoplasmosis: Zoonosis de importancia en población ocupacionalmente expuesta. Biosalud. 2008, 7: 21-27.Google Scholar
  40. Betancur CA, Jaramillo JM, Puyana JD, Quintero MI, Estrada S, Salazar LM: Seroprevalencia de toxoplasmosis en donantes de sangre de la Clínica Cardiovascular Santa María, Medellín, Colombia, 2009–2010. Infectio. 2011, 15: 14-19. 10.1016/S0123-9392(11)70071-6.View ArticleGoogle Scholar
  41. González-Parra GC, Arenas AJ, Aranda DF, Villanueva RJ, Jódar L: Dynamics of a model of Toxoplasmosis disease in human and cat populations. Comp Math Appl. 2009, 57: 1692-1700. 10.1016/j.camwa.2008.09.012.View ArticleGoogle Scholar
  42. Arenas AJ, González-Parra G, Villanueva MR-J: Modeling toxoplasmosis spread in cat populations under vaccination. Theor Popul Biol. 2010, 77: 227-237. 10.1016/j.tpb.2010.03.005.View ArticlePubMedGoogle Scholar
  43. Trejos D, Duarte I, Villegas A: Modelo matemático de la propagación de la infección por Toxoplasma gondii en gestantes con dos mecanismos de trasmisión. Rev Invest UniQuindio. 2006, 16: 181-187.Google Scholar
  44. Ocampo LM, Duarte-Gandica I: Modelo para la dinámica de transmisión de la toxoplasmosis congénita. Rev Salud Publica. 2010, 12: 317-326. 10.1590/S0124-00642010000200015.View ArticlePubMedGoogle Scholar
  45. Duarte GI: Un modelo difusión-advección para la propagación de Toxoplasma gondii. Rev Invest UniQuindio. 2012, 23: 36-49.Google Scholar
  46. Sánchez C, Yurgaky JM, Rodríguez F: Toxoplasmosis pulmonar en paciente immuncompetente. Reporte de caso y revisión de literatura. Rev Fac Med. 2009, 17: 268-273.Google Scholar
  47. Barrios JE, Duran BC, González VT: Nephrotic syndrome with a nephritic component associated with toxoplasmosis in a immuncompetent young man. Colomb Med. 2012, 43: 226-229.PubMedGoogle Scholar
  48. Restrepo IM: Toxoplasmosis: Zoonosis parasitaria. Rev CES Med. 2007, 21 (Suppl1): 41-48.Google Scholar
  49. Pino LE, Salinas JE, López MC: Descripción de un brote epidémico de toxoplasmosis aguda en pacientes inmunocompetentes miembros de las fuerzas militares de Colombia durante operaciones de selva. Infectio. 2009, 13: 83-91. 10.1016/S0123-9392(09)70729-5.View ArticleGoogle Scholar
  50. Díaz H, Manotas R: Toxoplasmosis congénita. Aspectos neurológicos en 27 casos de presentación posnatal. Acta Pediátr Colomb. 1983, 1: 8-15.Google Scholar
  51. Gómez-Marín JE, Castaño JC, Montoya LMT, Loango N, López C, Sarmiento MC, Pinzon L, Alvarado F: Toxoplasmosis congénita en Colombia: Análisis clínico y de laboratorio en 27 casos. Pediatr. 2000, 35: 52-57.Google Scholar
  52. Gómez JE: Evaluación del tratamiento de la toxoplasmosis gestacional en una cohorte colombiana. Infectio. 2005, 9: 16-23.Google Scholar
  53. Gallego-Marín C, Henao AC, Gómez-Marín JE: Clinical validation of a Western blot assay for congenital toxoplasmosis and newborn screening in a hospital in Armenia (Quindío) Colombia. J Trop Pediatr. 2006, 52: 107-112.View ArticlePubMedGoogle Scholar
  54. Gómez-Marín JE, González MM, Montoya MT, Giraldo A, Castaño JC: A newborn screening programme for congenital toxoplasmosis in the setting of a country with less income. Arch Dis Child. 2007, 92: 88-10.1136/adc.2006.106922.View ArticleGoogle Scholar
  55. Hortúa A, Beltrán S, Ossa H: Detección de toxoplasmosis congénita en líquido amniótico humano mediante la técnica de nested-PCR. Acta Biol Colomb. 2000, 5: 15-17.Google Scholar
  56. Blanco PJ, Assia YM, Montero YM, Orozco KE: ELFA IgG anti-Toxoplasma y PCR anidada para el diagnóstico de toxoplasmosis en mujeres gestantes de Sincelejo, Colombia. Infectio. 2011, 15: 253-258. 10.1016/S0123-9392(11)70739-1.View ArticleGoogle Scholar
  57. Madero VG, Cerquera CFM, Borrero BL: Toxoplasmosis cerebral congénita: Reporte de un caso. Rev Colomb Radiol. 2009, 20: 2784-2788.Google Scholar
  58. Gómez JE, Castaño JC, Ríos MP, Montoya MT: Toxoplasmosis congenita e hidranencefalia. Acta Med Colomb. 1992, 17: 457-458.Google Scholar
  59. Estrada M, De-la-Torre A, Gómez-Marín JE: Diagnóstico prenatal ecográfico de catarata en un caso de toxoplasmosis congénita, Quindío (Colombia). Rev Colomb Obstet Ginecol. 2010, 61: 267-272.Google Scholar
  60. Muñoz DM, Arroyave YA, Galeano GA, Calambás LC, Pérez FA, Martínez GA, Delgado MF: Toxoplasmosis congénita: Caso clínico e indicación del tratamiento con corticoesteróides. Revista Ciencias de la Salud. 2011, 13: 00-00.Google Scholar
  61. Thiébaut R, Leproust S, Chêne G, Gilbert R, SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group: Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet. 2007, 369: 115-122.View ArticlePubMedGoogle Scholar
  62. Gallego C, Castaño JC, Giraldo A, Ajzenberg D, Dardé ML, Gómez JE: Caracterización biológica y molecular del aislado CIBMUQ/HDC, una cepa colombiana de referencia para Toxoplasma gondii. Biomedica. 2004, 24: 282-290. 10.7705/biomedica.v24i3.1274.View ArticlePubMedGoogle Scholar
  63. López-Castillo CA, Díaz-Ramírez J, Gómez-Marín JE: Factores de riesgo en mujeres embarazadas, infectadas por Toxoplasma gondii en Armenia - Colombia. Rev Salud Publica. 2005, 7: 180-190.View ArticlePubMedGoogle Scholar
  64. Guzmán N, Bazurdo S, Oróstegui M, Ortega E: Instituto para niños ciegos y sordos de Cali: algunos aspectos epidemiológicos. Acta Pediatr Colomb. 1985, 3: 20-21.Google Scholar
  65. Zuluaga C, Sierra MV, Asprilla E: Causas de ceguera infantil en Cali, Colombia. Colomb Med. 2005, 36: 235-238.Google Scholar
  66. De-la-Torre A, López-Castillo CA, Gómez-Marín JE: Incidence and clinical characteristics in a Colombian cohort of ocular toxoplasmosis. Eye. 2009, 23: 1090-1093. 10.1038/eye.2008.219.View ArticlePubMedGoogle Scholar
  67. De-la-Torre A, López-Castillo CA, Rueda JC, Mantilla RD, Gómez-Marín JE, Anaya J-M: Clinical patterns of uveitis in two ophthalmology centres in Bogotá, Colombia. Clin Exp Ophthalmol. 2009, 37: 458-466. 10.1111/j.1442-9071.2009.02082.x.View ArticleGoogle Scholar
  68. De-la-Torre A, González-López G, Montoya-Gutierrez JM, Marín-Arango V, Gómez-Marín JE: Quality of life assessment in ocular toxoplasmosis in a Colombian population. Ocul Immunol Inflamm. 2011, 19: 262-266. 10.3109/09273948.2011.582220.View ArticlePubMedGoogle Scholar
  69. De-la-Torre A, López CA, Gómez JE: Vitreítis sin retinocoroiditis en toxoplasmosis ocular. Infectio. 2005, 9: 244-248.Google Scholar
  70. De-la-Torre A, Ríos-Cadavid AC, Cardozo-García CM, Gómez-Marín JE: Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral centre in Colombia. Br J Ophthalmol. 2009, 93: 1001-1004. 10.1136/bjo.2008.155861.View ArticlePubMedGoogle Scholar
  71. Montoya MT, Gómez JE, Castaño JC, Marx C, Aubert D, Bonhomme A, Pinon JM: Avances diagnósticos en toxoplasmosis. PCR, nuevos marcadores de infección evolutiva y otras técnicas. Acta Med Colomb. 1996, 21: 127-138.Google Scholar
  72. Lizarazo J, Castro F, de Arco M, Chaves O, Peña Y: Infecciones oportunistas del sistema nervioso central en pacientes con VIH atendidos en el Hospital Universitario Erasmo Meoz, Cúcuta, 1995–2005. Infectio. 2006, 10: 226-231.Google Scholar
  73. Mantilla JC, Cárdenas N: Hallazgos neuropatológicos de la infección por VIH-SIDA: estudio de autopsias en el Hospital Universitario de Santander, Bucaramanga, Colombia. Colomb Med. 2009, 40: 422-431.Google Scholar
  74. Luna TRL, Sandoval J, Gualtero LDM, Rodríguez VIE: Toxoplasmosis cerebral asociada a VIH-SIDA. Reporte de un caso. Rev Mex Patol Clin. 2009, 56: 283-285.Google Scholar
  75. Cardona N, Basto N, Parra B, Zea AF, Pardo CA, Bonelo A, Gómez-Marín JE: Detection of Toxoplasma DNA in the peripheral blood of HIV-positive patients with neuro-opportunistic infections by a Real-Time PCR assay. J Neuroparasitol. 2011, 2: 1-6.View ArticleGoogle Scholar
  76. Bernal-Cano F, Suaréz JO, Alvarez CA, Lowenstein E, Valderrama SL, Gómez CH, Tamara JR: Coriorretinitis por Toxoplasma gondii en contexto de un síndrome de reconstitución inmunológica inflamatorio en un paciente con síndrome de inmunodeficiencia adquirida SIDA. Acta Neurol Colomb. 2011, 27: 63-68.Google Scholar
  77. Rodríguez C, Martínez E, Bolívar G, Sánchez S, Carrascal E: Toxoplasmosis of the spinal cord in an immunocompromised patient: case report and review of the literature. Colomb Med. 2013, 44: 232-235.PubMedGoogle Scholar
  78. Perry BD, Mogollon JD, Grieve AS, De Galvis ALH: Serological study of ovine toxoplasmosis in Colombia: epidemiological study of a field outbreak. Vet Rec. 1979, 104: 231-234. 10.1136/vr.104.11.231.View ArticlePubMedGoogle Scholar
  79. Sanmartin C, Ayala SC: Toxoplasma in animals submitted for rabies diagnosis in Cali, Colombia. Trans R Soc Trop Med Hyg. 1972, 66: 799-10.1016/0035-9203(72)90099-5.View ArticlePubMedGoogle Scholar
  80. Parra L, Morales A: Incidencia de la toxoplasmosis en sueros humanos y caninos por medio de la fijación de complemento. Antioquia Med. 1965, 15: 327-Google Scholar
  81. Dubey JP, Cortés-Vecino JA, Vargas-Duarte JJ, Sundar N, Velmurugan GV, Bandini LM, Polo LJ, Zambrano L, Mora LE, Kwok OCH, Smith T, Su C: Prevalence of Toxoplasma gondii in dogs from Colombia, South America and genetic characterization of T. gondii isolates. Vet Parasitol. 2007, 145: 45-50. 10.1016/j.vetpar.2006.12.001.View ArticlePubMedGoogle Scholar
  82. Dubey JP, Su C, Cortés JA, Sundar N, Gómez-Marín JE, Polo LJ, Zambrano L, Mora LE, Lora F, Jimenez J, Kwok OCH, Shen SK, Zhang X, Nieto A, Thulliez P: Prevalence of Toxoplasma gondii in cats from Colombia, South America and genetic characterization of T. gondii isolates. Vet Parasitol. 2006, 141: 42-47. 10.1016/j.vetpar.2006.04.037.View ArticlePubMedGoogle Scholar
  83. Pérez CJE, Aricapa GHJ, Candelo RSM, Guevara GLA, Meza OJA, Correa SRA: Prevalencia de anticuerpos anti-Toxoplasma gondii en cuatro especies de consumo humano en Caldas-Colombia. Biosalud. 2006, 5: 33-42.Google Scholar
  84. Montoya MF, Ramírez EL, Loaiza HA, Henao CJ, Murillo GG: Prevalencia de anticuerpos para Toxoplasma gondii en bovinos y porcinos. Bol Of Sanit Panam. 1981, 91: 219-227.Google Scholar
  85. Dubey JP, Gómez-Marín JE, Bedoya A, Lora F, Vianna MCB, Hill D, Kwok OCH, Shen SK, Marcet PL, Lehmann T: Genetic and biologic characteristics of Toxoplasma gondii isolates in free-range chickens from Colombia, South America. Vet Parasitol. 2005, 134: 67-72. 10.1016/j.vetpar.2005.07.013.View ArticlePubMedGoogle Scholar
  86. Perry BD, Grieve AS, Mogollon JD, De Galvis ALH: Serological study of ovine toxoplasmosis in Colombia: prevalence of haemagglutinating antibodies to toxoplasma in sheep. Vet Rec. 1978, 103: 584-585. 10.1136/vr.103.26-27.584.View ArticlePubMedGoogle Scholar
  87. Rajendran C, Su C, Dubey JP: Molecular genotyping of Toxoplasma gondii from Central and South America revealed high diversity within and between population. Infect Genet Evol. 2012, 12: 359-368. 10.1016/j.meegid.2011.12.010.View ArticlePubMedGoogle Scholar
  88. Montoya LMT, Loango CN, Sierra IM, Castaño OJC: Infección por Toxoplasma gondii en gatos de dos barrios del sur de Armenia y su importancia en la toxoplasmosis humana. COLB. 1998, 12: 18-23.Google Scholar
  89. Herrera C, De Sánchez N, Hortúa A, Beltrán S, Contreras Y: Caracterización biológica y antigénica de cepas de Toxoplasma gondii aisladas de carnes de cerdo en un frigorífico de Bogotá. Infectio. 2005, 9: 131-138.Google Scholar
  90. Grogl M, Marinkelle CJ, Alvarado R, De Sánchez N, Guhl F: El cerdo como fuente potencial de toxoplasmosis e isosporosis humana en Colombia. Antioquia Med. 1979, 28: 14-16.Google Scholar
  91. Montoya MF: Toxoplasmosis animal y en manipuladores de carne en Colombia. Antioquia Med. 1983, 32: 33-35.Google Scholar
  92. Lora F, Aricapa HJ, Pérez JE, Arias LE, Idarraga SE, Mier D, Gómez JE: Detección de Toxoplasma gondii en carnes de consumo humano por la técnica de reacción en cadena de la polimerasa en tres ciudades del eje cafetero. Infectio. 2007, 11: 117-123.Google Scholar
  93. Frenkel JK, Hassanein KM, Hassanein RS, Brown E, Thulliez P, Quintero-Nunez R: Transmission of Toxoplasma gondii in Panamá city, Panamá: A five-year prospective cohort study of children, cats, rodents, birds, and soil. Am J Trop Med Hyg. 1995, 53: 458-468.PubMedGoogle Scholar
  94. Peyron F, Lobry JR, Musset K, Ferrandiz J, Gómez-Marín JE, Petersen E, Meroni V, Rausher B, Mercier C, Picot S, Cesbron-Delauw M-F: Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect. 2006, 8: 2333-2340. 10.1016/j.micinf.2006.03.023.View ArticlePubMedGoogle Scholar
  95. Gallego C, Saavedra-Matiz C, Gómez-Marín JE: Direct genotyping of animal and human isolates of Toxoplasma gondii from Colombia (South America). Acta Trop. 2006, 97: 161-167. 10.1016/j.actatropica.2005.10.001.View ArticlePubMedGoogle Scholar
  96. Howe DK, Sibley LD: Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 1995, 172: 1561-1566. 10.1093/infdis/172.6.1561.View ArticlePubMedGoogle Scholar
  97. Dubey JP, Van Why K, Verma SK, Choudhary S, Kwok OC, Khan A, Behinke MS, Sibley LD, Ferreira LR, Oliveira S, Weaber M, Stewart R, Su C: Genotyping Toxoplasma gondii from wildlife in Pennsylvania and identification of natural recombinants virulent to mice. Vet Parasitol. 2014, 200: 74-84. 10.1016/j.vetpar.2013.11.001.PubMed CentralView ArticlePubMedGoogle Scholar
  98. Sánchez V, De-la-Torre A, Gómez-Marín JE: Characterization of ROP18 alleles in human toxoplasmosis. Parasitol International. 2014, 63: 463-469. 10.1016/j.parint.2013.10.012.View ArticleGoogle Scholar
  99. Torres-Morales E, Taborda L, Cardona N, De-la-Torre A, Sepulveda-Arias JC, Patarroyo MA, Gómez-Marín JE: Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis. Med Microbiol Immunol. 2014, in pressGoogle Scholar
  100. De-la-Torre A, Pfaff AW, Grigg ME, Villard O, Candolfi E, Gómez-Marín JE: Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis. Cytokine. 2014, 68: 23-31. 10.1016/j.cyto.2014.03.005.View ArticlePubMedGoogle Scholar

Copyright

© Cañón-Franco et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement